Tampus, Evabel .

HRN: 25-04-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CEFUROXIME 1.5GM (VIAL)
06/08/2024
06/08/2024
IVT
1.5g
On Call To OR
AUB Secondary To Myoma Subserous
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: